Drug Eluting Stent Market in China - Industry Research Report 2015-2019

Date: October 7, 2015
Pages: 56
Price:
US$ 2,500.00
License [?]:
Publisher: Infiniti Research
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: D9A92AE1CBDEN
Leaflet:

Download PDF Leaflet

About drug eluting stent

Drug eluting stent, also known as medicated coronary stent, is a tiny, expandable metal mesh tube that is covered with a pharmacologic agent. It prevents artery blockages in patients after angioplasty. It also eliminates the need for repeated revascularization procedures that are used to treat restenosis (narrowing of blood vessels).

Technavio's analysts forecast the drug eluting stent market in China to grow at a CAGR of 10.70% over the period 2014-2019.

Covered in this report

This report covers the present and future scenario of the drug eluting stent market in China for the period 2015-2019. To calculate the market size, Technavio uses revenue generated from the sales of drug eluting stents.

Technavio's report, Drug Eluting Stent Market in China 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the landscape of the drug eluting stent market in China and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.

Key vendors
  • Abbott Vascular
  • Lepu Medical
  • Medtronic
  • MicroPort Scientific
  • Shandong JW Medical Systems
Other prominent vendors
  • Biosensors International
  • Boston Scientific
  • Cook Medical
  • Opto Circuit
  • QualiMed
  • Sinomed
  • Terumo Medical
Market driver
  • High prevalence of CVDs
  • For a full, detailed list, view our report
Market challenge
  • Availability of alternative coronary stents
  • For a full, detailed list, view our report
Market trend
  • Increase in demand for minimally-invasive procedures
  • For a full, detailed list, view our report
Key questions answered in this report
  • What will the market size be in 2019 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?
PART 01: EXECUTIVE SUMMARY

Highlights

PART 02: SCOPE OF THE REPORT

Market overview
Top-vendor offerings

PART 03: MARKET RESEARCH METHODOLOGY

Research methodology
Economic indicators

PART 04: INTRODUCTION

Key market highlights

PART 05: STENTS: AN OVERVIEW

Stents

PART 06: MARKET LANDSCAPE

Market overview
Five force analysis

PART 07: HEALTHCARE REFORM IN CHINA

PART 08: OPPORTUNITIES FOR GLOBAL AND LOCAL VENDORS

Local vendors
Global vendors

PART 09: MARKET DRIVERS

High prevalence of CVDs
Advances in technology
Favorable reimbursement policies
Low risk of contracting restenosis

PART 10: IMPACT OF DRIVERS

PART 11: MARKET CHALLENGES

Availability of alternative coronary stents
Limitations of drug-eluting stents
Stringent regulations for device approval
Preference for drugs over stents

PART 12: IMPACT OF DRIVERS AND CHALLENGES

PART 13: MARKET TRENDS

Increased demand for minimally invasive procedures
Government support for local manufacturers
Growing popularity of hybrid procedures
Popularity of medical tourism

PART 14: VENDOR LANDSCAPE

Competitive scenario
Major vendor analysis 2014
Other prominent vendors

PART 15: KEY VENDOR ANALYSIS

MicroPort
Lepu Medical Technology
JW Medical Systems
Abbott Vascular
Medtronic
Business overview

PART 16: APPENDIX

List of abbreviations

PART 17: EXPLORE TECHNAVIO

LIST OF EXHIBITS

Exhibit 01: Product offerings
Exhibit 02: Cross-sectional view of a stent with drug-loaded polymeric coating
Exhibit 03: Some agents used in drug eluting stents
Exhibit 04: Brief history of stents
Exhibit 05: Drug eluting stent market in China 2014-2019 ($ millions)
Exhibit 06: Five forces analysis
Exhibit 07: Disease mortality in China 2014
Exhibit 08: Healthcare reforms in China
Exhibit 09: Number of medical institutes in China until 2012
Exhibit 10: Impact of drivers
Exhibit 11: Impact of drivers and challenges
Exhibit 12: Market share analysis of vendors
Exhibit 13: Microport Medical: Key takeaways
Exhibit 14: Lepu Medical: Key takeaways
Exhibit 15: Shandong JW Medical System: Key takeaways
Exhibit 16: Abbott Vascular: Key takeaways
Exhibit 17: Medtronic: Key takeaways
Exhibit 18: Microport: Business segmentation 2014 by revenue
Exhibit 19: MicroPort: Business segmentation by revenue 2013 and 2014 ($ millions)
Exhibit 20: Lepu Medical Technology: Product segmentation
Exhibit 21: Lepu Medical Technology: Revenue breakup 2014
Exhibit 22: JW Medical Systems: Product portfolio
Exhibit 23: Abbott Vascular: Product categories
Skip to top


The Drug-Eluting Stent Market Outlook to 2016 US$ 3,835.00 Mar, 2011 · 115 pages
Drug Eluting Stent Coatings – New Horizons US$ 500.00 Dec, 2008 · 14 pages
U.S. Market for Drug-Eluting and Bare Metal Stents 2009 US$ 4,495.00 May, 2009 · 65 pages

Ask Your Question

Drug Eluting Stent Market in China - Industry Research Report 2015-2019
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: